Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
Olivier Loeillot President and Chief Commercial Officer WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE Healthcare Life Sciences
United States Sondras Newman Cytivaa Danaher Olivier Loeillot Master Of Business Administration Repligen Corporation
Source: yahoo.com